This chronic myeloid leukemia (CML) model may help direct treatment for patients in the future.
Population-wide care ought to be optimal, regardless of region, argue the authors of a recent study.
Hematologic Cancers News
More Hematologic Cancers Information
Non-Hodgkin lymphoma (NHL) is a group of cancers affecting cells called lymphocytes in the lymphatic system.
A diagnosis of Waldenstrom's Macroglobulinemia can leave you and your loved ones feeling uncertain, anxious and overwhelmed.
Bone marrow transplants are an important treatment option for people with blood cancers.
Your oncologist, other doctors, and nurses are a great source of information about treatment options, pain and side effect management, and other medical concerns.
This fact sheet provides patients with acute lymphocytic leukemia strategies for coping, treatment options, and more.
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|
|Renal Cell Carcinoma||Regimens||Drugs|
Cancer Therapy Advisor Articles
- Insurance Plans Dropping Coverage of FDA-approved BRCA Diagnostic Test
- Genomic Information and the Future of Health Care
- Lartruvo (Olaratumab) Offers New Promise for Patients With Soft Tissue Sarcoma
- FDA Approves Atezolizumab (Tecentriq) for Treatment of Metastatic NSCLC
- Less Frequent Cervical Cancer Screenings May Be Okay After HPV Vaccine
- Study Affirms Activity of Nivolumab in Heavily Pretreated Classical Hodgkin Lymphoma
- Localized Consolidative Therapy May Be Effective in Oligometastatic NSCLC
- Adaptive Randomization and the I-SPY 2 Trial Platform
- Tivozanib Shows Antitumor Activity in Metastatic Soft Tissue Sarcoma
- FDA Approves Pembrolizumab for PD-L1-expressing Metastatic NSCLC